As such, the pathology identified here is best placed in context of the progressive, widespread TDP-43 proteinopathy recently characterized as stage III and stage IV for ALS TDP-43 pathology [35]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.